WHO
REGULATORY UPDATE
Active Pharmaceutical Ingredient (API) Prequalified
Published: 11/18/2026Detected: 11/18/2026
Summary preview
WHO prequalification status is announced for pyrazinamide API from Zhejiang Haizhou Pharmaceutical Co., Ltd., enabling manufacturers of finished pharmaceutical products (FPPs) to source a vetted API for tuberculosis…
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountinfectious_disease
manufacturing
quality
#WHO prequalification
#API prequalification
#APIMF
#WHO GMP
#pyrazinamide
Official Source Document Source Verified
Access the original document directly from WHO.